Idraparinux secondary prophylaxis vs vitamin K antagonist secondary prophylaxis
Health‐related quality of life ‐ not reported · people with cancer with VTE receiving secondary prophylaxis
The review found no eligible studies for this question.
1 finding from 1 review
- Anticoagulation for the long‐term treatment of venous thromboembolism in people with cancer 2018 · Cochrane Headline outcomes onlyno estimate extractedStudies not reportedNo studies found